Global Antibody Drug Conjugates (ADCs) Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Antibody Drug Conjugates (ADCs) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue. ADCs are part of a specialized subset of highly potent APIs. This technically challenging type of therapy combines innovations from biotechnology and chemistry to form a new class of highly potent biopharmaceutical drugs.
Advances in coupling antibodies to cytotoxic drugs permit greater control of drug pharmacokinetics and significantly improve delivery to target tissue. Potent new anti-cancer drugs can now be used to target cancers while minimizing exposure of healthy tissue.
The Global Info Research report includes an overview of the development of the Antibody Drug Conjugates (ADCs) industry chain, the market status of Hospital (Seattle Genetics Technology, ImmunoGen Technology), Clinics (Seattle Genetics Technology, ImmunoGen Technology), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antibody Drug Conjugates (ADCs).
Regionally, the report analyzes the Antibody Drug Conjugates (ADCs) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antibody Drug Conjugates (ADCs) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Antibody Drug Conjugates (ADCs) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antibody Drug Conjugates (ADCs) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Seattle Genetics Technology, ImmunoGen Technology).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antibody Drug Conjugates (ADCs) market.
Regional Analysis: The report involves examining the Antibody Drug Conjugates (ADCs) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antibody Drug Conjugates (ADCs) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Antibody Drug Conjugates (ADCs):
Company Analysis: Report covers individual Antibody Drug Conjugates (ADCs) players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antibody Drug Conjugates (ADCs) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinics).
Technology Analysis: Report covers specific technologies relevant to Antibody Drug Conjugates (ADCs). It assesses the current state, advancements, and potential future developments in Antibody Drug Conjugates (ADCs) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antibody Drug Conjugates (ADCs) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Antibody Drug Conjugates (ADCs) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Antibody Drug Conjugates (ADCs) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antibody Drug Conjugates (ADCs), with revenue, gross margin and global market share of Antibody Drug Conjugates (ADCs) from 2019 to 2024.
Chapter 3, the Antibody Drug Conjugates (ADCs) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Antibody Drug Conjugates (ADCs) market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibody Drug Conjugates (ADCs).
Chapter 13, to describe Antibody Drug Conjugates (ADCs) research findings and conclusion.
Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue. ADCs are part of a specialized subset of highly potent APIs. This technically challenging type of therapy combines innovations from biotechnology and chemistry to form a new class of highly potent biopharmaceutical drugs.
Advances in coupling antibodies to cytotoxic drugs permit greater control of drug pharmacokinetics and significantly improve delivery to target tissue. Potent new anti-cancer drugs can now be used to target cancers while minimizing exposure of healthy tissue.
The Global Info Research report includes an overview of the development of the Antibody Drug Conjugates (ADCs) industry chain, the market status of Hospital (Seattle Genetics Technology, ImmunoGen Technology), Clinics (Seattle Genetics Technology, ImmunoGen Technology), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antibody Drug Conjugates (ADCs).
Regionally, the report analyzes the Antibody Drug Conjugates (ADCs) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antibody Drug Conjugates (ADCs) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Antibody Drug Conjugates (ADCs) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antibody Drug Conjugates (ADCs) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Seattle Genetics Technology, ImmunoGen Technology).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antibody Drug Conjugates (ADCs) market.
Regional Analysis: The report involves examining the Antibody Drug Conjugates (ADCs) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antibody Drug Conjugates (ADCs) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Antibody Drug Conjugates (ADCs):
Company Analysis: Report covers individual Antibody Drug Conjugates (ADCs) players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antibody Drug Conjugates (ADCs) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinics).
Technology Analysis: Report covers specific technologies relevant to Antibody Drug Conjugates (ADCs). It assesses the current state, advancements, and potential future developments in Antibody Drug Conjugates (ADCs) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antibody Drug Conjugates (ADCs) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Antibody Drug Conjugates (ADCs) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Seattle Genetics Technology
- ImmunoGen Technology
- Immunomedics Technology
- Hospital
- Clinics
- Others
- Roche
- Pfizer
- Novartis
- Genmab
- Bayer
- Seattle Genetics
- Takeda Pharmaceuticals
- AbbVie
- AbGenomics
- ADC Therapeutics
- Astellas Pharma
- Kairos Therapeutics
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Antibody Drug Conjugates (ADCs) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antibody Drug Conjugates (ADCs), with revenue, gross margin and global market share of Antibody Drug Conjugates (ADCs) from 2019 to 2024.
Chapter 3, the Antibody Drug Conjugates (ADCs) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Antibody Drug Conjugates (ADCs) market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibody Drug Conjugates (ADCs).
Chapter 13, to describe Antibody Drug Conjugates (ADCs) research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Antibody Drug Conjugates (ADCs)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Antibody Drug Conjugates (ADCs) by Type
1.3.1 Overview: Global Antibody Drug Conjugates (ADCs) Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Type in 2023
1.3.3 Seattle Genetics Technology
1.3.4 ImmunoGen Technology
1.3.5 Immunomedics Technology
1.4 Global Antibody Drug Conjugates (ADCs) Market by Application
1.4.1 Overview: Global Antibody Drug Conjugates (ADCs) Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinics
1.4.4 Others
1.5 Global Antibody Drug Conjugates (ADCs) Market Size & Forecast
1.6 Global Antibody Drug Conjugates (ADCs) Market Size and Forecast by Region
1.6.1 Global Antibody Drug Conjugates (ADCs) Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Antibody Drug Conjugates (ADCs) Market Size by Region, (2019-2030)
1.6.3 North America Antibody Drug Conjugates (ADCs) Market Size and Prospect (2019-2030)
1.6.4 Europe Antibody Drug Conjugates (ADCs) Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Antibody Drug Conjugates (ADCs) Market Size and Prospect (2019-2030)
1.6.6 South America Antibody Drug Conjugates (ADCs) Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Antibody Drug Conjugates (ADCs) Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Antibody Drug Conjugates (ADCs) Product and Solutions
2.1.4 Roche Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Antibody Drug Conjugates (ADCs) Product and Solutions
2.2.4 Pfizer Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Antibody Drug Conjugates (ADCs) Product and Solutions
2.3.4 Novartis Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Genmab
2.4.1 Genmab Details
2.4.2 Genmab Major Business
2.4.3 Genmab Antibody Drug Conjugates (ADCs) Product and Solutions
2.4.4 Genmab Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Genmab Recent Developments and Future Plans
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Antibody Drug Conjugates (ADCs) Product and Solutions
2.5.4 Bayer Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Bayer Recent Developments and Future Plans
2.6 Seattle Genetics
2.6.1 Seattle Genetics Details
2.6.2 Seattle Genetics Major Business
2.6.3 Seattle Genetics Antibody Drug Conjugates (ADCs) Product and Solutions
2.6.4 Seattle Genetics Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Seattle Genetics Recent Developments and Future Plans
2.7 Takeda Pharmaceuticals
2.7.1 Takeda Pharmaceuticals Details
2.7.2 Takeda Pharmaceuticals Major Business
2.7.3 Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Product and Solutions
2.7.4 Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Takeda Pharmaceuticals Recent Developments and Future Plans
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business
2.8.3 AbbVie Antibody Drug Conjugates (ADCs) Product and Solutions
2.8.4 AbbVie Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 AbbVie Recent Developments and Future Plans
2.9 AbGenomics
2.9.1 AbGenomics Details
2.9.2 AbGenomics Major Business
2.9.3 AbGenomics Antibody Drug Conjugates (ADCs) Product and Solutions
2.9.4 AbGenomics Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 AbGenomics Recent Developments and Future Plans
2.10 ADC Therapeutics
2.10.1 ADC Therapeutics Details
2.10.2 ADC Therapeutics Major Business
2.10.3 ADC Therapeutics Antibody Drug Conjugates (ADCs) Product and Solutions
2.10.4 ADC Therapeutics Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 ADC Therapeutics Recent Developments and Future Plans
2.11 Astellas Pharma
2.11.1 Astellas Pharma Details
2.11.2 Astellas Pharma Major Business
2.11.3 Astellas Pharma Antibody Drug Conjugates (ADCs) Product and Solutions
2.11.4 Astellas Pharma Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Astellas Pharma Recent Developments and Future Plans
2.12 Kairos Therapeutics
2.12.1 Kairos Therapeutics Details
2.12.2 Kairos Therapeutics Major Business
2.12.3 Kairos Therapeutics Antibody Drug Conjugates (ADCs) Product and Solutions
2.12.4 Kairos Therapeutics Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Kairos Therapeutics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Antibody Drug Conjugates (ADCs) Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Antibody Drug Conjugates (ADCs) by Company Revenue
3.2.2 Top 3 Antibody Drug Conjugates (ADCs) Players Market Share in 2023
3.2.3 Top 6 Antibody Drug Conjugates (ADCs) Players Market Share in 2023
3.3 Antibody Drug Conjugates (ADCs) Market: Overall Company Footprint Analysis
3.3.1 Antibody Drug Conjugates (ADCs) Market: Region Footprint
3.3.2 Antibody Drug Conjugates (ADCs) Market: Company Product Type Footprint
3.3.3 Antibody Drug Conjugates (ADCs) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Antibody Drug Conjugates (ADCs) Consumption Value and Market Share by Type (2019-2024)
4.2 Global Antibody Drug Conjugates (ADCs) Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Application (2019-2024)
5.2 Global Antibody Drug Conjugates (ADCs) Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Antibody Drug Conjugates (ADCs) Consumption Value by Type (2019-2030)
6.2 North America Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2030)
6.3 North America Antibody Drug Conjugates (ADCs) Market Size by Country
6.3.1 North America Antibody Drug Conjugates (ADCs) Consumption Value by Country (2019-2030)
6.3.2 United States Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
6.3.3 Canada Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
6.3.4 Mexico Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Antibody Drug Conjugates (ADCs) Consumption Value by Type (2019-2030)
7.2 Europe Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2030)
7.3 Europe Antibody Drug Conjugates (ADCs) Market Size by Country
7.3.1 Europe Antibody Drug Conjugates (ADCs) Consumption Value by Country (2019-2030)
7.3.2 Germany Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
7.3.3 France Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
7.3.5 Russia Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
7.3.6 Italy Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Antibody Drug Conjugates (ADCs) Market Size by Region
8.3.1 Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value by Region (2019-2030)
8.3.2 China Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
8.3.3 Japan Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
8.3.4 South Korea Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
8.3.5 India Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
8.3.7 Australia Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Antibody Drug Conjugates (ADCs) Consumption Value by Type (2019-2030)
9.2 South America Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2030)
9.3 South America Antibody Drug Conjugates (ADCs) Market Size by Country
9.3.1 South America Antibody Drug Conjugates (ADCs) Consumption Value by Country (2019-2030)
9.3.2 Brazil Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
9.3.3 Argentina Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Antibody Drug Conjugates (ADCs) Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Antibody Drug Conjugates (ADCs) Market Size by Country
10.3.1 Middle East & Africa Antibody Drug Conjugates (ADCs) Consumption Value by Country (2019-2030)
10.3.2 Turkey Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
10.3.4 UAE Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Antibody Drug Conjugates (ADCs) Market Drivers
11.2 Antibody Drug Conjugates (ADCs) Market Restraints
11.3 Antibody Drug Conjugates (ADCs) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Antibody Drug Conjugates (ADCs) Industry Chain
12.2 Antibody Drug Conjugates (ADCs) Upstream Analysis
12.3 Antibody Drug Conjugates (ADCs) Midstream Analysis
12.4 Antibody Drug Conjugates (ADCs) Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Antibody Drug Conjugates (ADCs)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Antibody Drug Conjugates (ADCs) by Type
1.3.1 Overview: Global Antibody Drug Conjugates (ADCs) Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Type in 2023
1.3.3 Seattle Genetics Technology
1.3.4 ImmunoGen Technology
1.3.5 Immunomedics Technology
1.4 Global Antibody Drug Conjugates (ADCs) Market by Application
1.4.1 Overview: Global Antibody Drug Conjugates (ADCs) Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinics
1.4.4 Others
1.5 Global Antibody Drug Conjugates (ADCs) Market Size & Forecast
1.6 Global Antibody Drug Conjugates (ADCs) Market Size and Forecast by Region
1.6.1 Global Antibody Drug Conjugates (ADCs) Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Antibody Drug Conjugates (ADCs) Market Size by Region, (2019-2030)
1.6.3 North America Antibody Drug Conjugates (ADCs) Market Size and Prospect (2019-2030)
1.6.4 Europe Antibody Drug Conjugates (ADCs) Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Antibody Drug Conjugates (ADCs) Market Size and Prospect (2019-2030)
1.6.6 South America Antibody Drug Conjugates (ADCs) Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Antibody Drug Conjugates (ADCs) Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Antibody Drug Conjugates (ADCs) Product and Solutions
2.1.4 Roche Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Antibody Drug Conjugates (ADCs) Product and Solutions
2.2.4 Pfizer Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Antibody Drug Conjugates (ADCs) Product and Solutions
2.3.4 Novartis Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Genmab
2.4.1 Genmab Details
2.4.2 Genmab Major Business
2.4.3 Genmab Antibody Drug Conjugates (ADCs) Product and Solutions
2.4.4 Genmab Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Genmab Recent Developments and Future Plans
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Antibody Drug Conjugates (ADCs) Product and Solutions
2.5.4 Bayer Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Bayer Recent Developments and Future Plans
2.6 Seattle Genetics
2.6.1 Seattle Genetics Details
2.6.2 Seattle Genetics Major Business
2.6.3 Seattle Genetics Antibody Drug Conjugates (ADCs) Product and Solutions
2.6.4 Seattle Genetics Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Seattle Genetics Recent Developments and Future Plans
2.7 Takeda Pharmaceuticals
2.7.1 Takeda Pharmaceuticals Details
2.7.2 Takeda Pharmaceuticals Major Business
2.7.3 Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Product and Solutions
2.7.4 Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Takeda Pharmaceuticals Recent Developments and Future Plans
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business
2.8.3 AbbVie Antibody Drug Conjugates (ADCs) Product and Solutions
2.8.4 AbbVie Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 AbbVie Recent Developments and Future Plans
2.9 AbGenomics
2.9.1 AbGenomics Details
2.9.2 AbGenomics Major Business
2.9.3 AbGenomics Antibody Drug Conjugates (ADCs) Product and Solutions
2.9.4 AbGenomics Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 AbGenomics Recent Developments and Future Plans
2.10 ADC Therapeutics
2.10.1 ADC Therapeutics Details
2.10.2 ADC Therapeutics Major Business
2.10.3 ADC Therapeutics Antibody Drug Conjugates (ADCs) Product and Solutions
2.10.4 ADC Therapeutics Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 ADC Therapeutics Recent Developments and Future Plans
2.11 Astellas Pharma
2.11.1 Astellas Pharma Details
2.11.2 Astellas Pharma Major Business
2.11.3 Astellas Pharma Antibody Drug Conjugates (ADCs) Product and Solutions
2.11.4 Astellas Pharma Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Astellas Pharma Recent Developments and Future Plans
2.12 Kairos Therapeutics
2.12.1 Kairos Therapeutics Details
2.12.2 Kairos Therapeutics Major Business
2.12.3 Kairos Therapeutics Antibody Drug Conjugates (ADCs) Product and Solutions
2.12.4 Kairos Therapeutics Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Kairos Therapeutics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Antibody Drug Conjugates (ADCs) Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Antibody Drug Conjugates (ADCs) by Company Revenue
3.2.2 Top 3 Antibody Drug Conjugates (ADCs) Players Market Share in 2023
3.2.3 Top 6 Antibody Drug Conjugates (ADCs) Players Market Share in 2023
3.3 Antibody Drug Conjugates (ADCs) Market: Overall Company Footprint Analysis
3.3.1 Antibody Drug Conjugates (ADCs) Market: Region Footprint
3.3.2 Antibody Drug Conjugates (ADCs) Market: Company Product Type Footprint
3.3.3 Antibody Drug Conjugates (ADCs) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Antibody Drug Conjugates (ADCs) Consumption Value and Market Share by Type (2019-2024)
4.2 Global Antibody Drug Conjugates (ADCs) Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Application (2019-2024)
5.2 Global Antibody Drug Conjugates (ADCs) Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Antibody Drug Conjugates (ADCs) Consumption Value by Type (2019-2030)
6.2 North America Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2030)
6.3 North America Antibody Drug Conjugates (ADCs) Market Size by Country
6.3.1 North America Antibody Drug Conjugates (ADCs) Consumption Value by Country (2019-2030)
6.3.2 United States Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
6.3.3 Canada Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
6.3.4 Mexico Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Antibody Drug Conjugates (ADCs) Consumption Value by Type (2019-2030)
7.2 Europe Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2030)
7.3 Europe Antibody Drug Conjugates (ADCs) Market Size by Country
7.3.1 Europe Antibody Drug Conjugates (ADCs) Consumption Value by Country (2019-2030)
7.3.2 Germany Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
7.3.3 France Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
7.3.5 Russia Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
7.3.6 Italy Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Antibody Drug Conjugates (ADCs) Market Size by Region
8.3.1 Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value by Region (2019-2030)
8.3.2 China Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
8.3.3 Japan Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
8.3.4 South Korea Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
8.3.5 India Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
8.3.7 Australia Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Antibody Drug Conjugates (ADCs) Consumption Value by Type (2019-2030)
9.2 South America Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2030)
9.3 South America Antibody Drug Conjugates (ADCs) Market Size by Country
9.3.1 South America Antibody Drug Conjugates (ADCs) Consumption Value by Country (2019-2030)
9.3.2 Brazil Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
9.3.3 Argentina Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Antibody Drug Conjugates (ADCs) Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Antibody Drug Conjugates (ADCs) Market Size by Country
10.3.1 Middle East & Africa Antibody Drug Conjugates (ADCs) Consumption Value by Country (2019-2030)
10.3.2 Turkey Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
10.3.4 UAE Antibody Drug Conjugates (ADCs) Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Antibody Drug Conjugates (ADCs) Market Drivers
11.2 Antibody Drug Conjugates (ADCs) Market Restraints
11.3 Antibody Drug Conjugates (ADCs) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Antibody Drug Conjugates (ADCs) Industry Chain
12.2 Antibody Drug Conjugates (ADCs) Upstream Analysis
12.3 Antibody Drug Conjugates (ADCs) Midstream Analysis
12.4 Antibody Drug Conjugates (ADCs) Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Antibody Drug Conjugates (ADCs) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Antibody Drug Conjugates (ADCs) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Antibody Drug Conjugates (ADCs) Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Antibody Drug Conjugates (ADCs) Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Antibody Drug Conjugates (ADCs) Product and Solutions
Table 8. Roche Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Roche Recent Developments and Future Plans
Table 10. Pfizer Company Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Antibody Drug Conjugates (ADCs) Product and Solutions
Table 13. Pfizer Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Pfizer Recent Developments and Future Plans
Table 15. Novartis Company Information, Head Office, and Major Competitors
Table 16. Novartis Major Business
Table 17. Novartis Antibody Drug Conjugates (ADCs) Product and Solutions
Table 18. Novartis Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Novartis Recent Developments and Future Plans
Table 20. Genmab Company Information, Head Office, and Major Competitors
Table 21. Genmab Major Business
Table 22. Genmab Antibody Drug Conjugates (ADCs) Product and Solutions
Table 23. Genmab Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Genmab Recent Developments and Future Plans
Table 25. Bayer Company Information, Head Office, and Major Competitors
Table 26. Bayer Major Business
Table 27. Bayer Antibody Drug Conjugates (ADCs) Product and Solutions
Table 28. Bayer Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Bayer Recent Developments and Future Plans
Table 30. Seattle Genetics Company Information, Head Office, and Major Competitors
Table 31. Seattle Genetics Major Business
Table 32. Seattle Genetics Antibody Drug Conjugates (ADCs) Product and Solutions
Table 33. Seattle Genetics Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Seattle Genetics Recent Developments and Future Plans
Table 35. Takeda Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 36. Takeda Pharmaceuticals Major Business
Table 37. Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Product and Solutions
Table 38. Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Takeda Pharmaceuticals Recent Developments and Future Plans
Table 40. AbbVie Company Information, Head Office, and Major Competitors
Table 41. AbbVie Major Business
Table 42. AbbVie Antibody Drug Conjugates (ADCs) Product and Solutions
Table 43. AbbVie Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. AbbVie Recent Developments and Future Plans
Table 45. AbGenomics Company Information, Head Office, and Major Competitors
Table 46. AbGenomics Major Business
Table 47. AbGenomics Antibody Drug Conjugates (ADCs) Product and Solutions
Table 48. AbGenomics Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. AbGenomics Recent Developments and Future Plans
Table 50. ADC Therapeutics Company Information, Head Office, and Major Competitors
Table 51. ADC Therapeutics Major Business
Table 52. ADC Therapeutics Antibody Drug Conjugates (ADCs) Product and Solutions
Table 53. ADC Therapeutics Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. ADC Therapeutics Recent Developments and Future Plans
Table 55. Astellas Pharma Company Information, Head Office, and Major Competitors
Table 56. Astellas Pharma Major Business
Table 57. Astellas Pharma Antibody Drug Conjugates (ADCs) Product and Solutions
Table 58. Astellas Pharma Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Astellas Pharma Recent Developments and Future Plans
Table 60. Kairos Therapeutics Company Information, Head Office, and Major Competitors
Table 61. Kairos Therapeutics Major Business
Table 62. Kairos Therapeutics Antibody Drug Conjugates (ADCs) Product and Solutions
Table 63. Kairos Therapeutics Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Kairos Therapeutics Recent Developments and Future Plans
Table 65. Global Antibody Drug Conjugates (ADCs) Revenue (USD Million) by Players (2019-2024)
Table 66. Global Antibody Drug Conjugates (ADCs) Revenue Share by Players (2019-2024)
Table 67. Breakdown of Antibody Drug Conjugates (ADCs) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Antibody Drug Conjugates (ADCs), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 69. Head Office of Key Antibody Drug Conjugates (ADCs) Players
Table 70. Antibody Drug Conjugates (ADCs) Market: Company Product Type Footprint
Table 71. Antibody Drug Conjugates (ADCs) Market: Company Product Application Footprint
Table 72. Antibody Drug Conjugates (ADCs) New Market Entrants and Barriers to Market Entry
Table 73. Antibody Drug Conjugates (ADCs) Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Antibody Drug Conjugates (ADCs) Consumption Value (USD Million) by Type (2019-2024)
Table 75. Global Antibody Drug Conjugates (ADCs) Consumption Value Share by Type (2019-2024)
Table 76. Global Antibody Drug Conjugates (ADCs) Consumption Value Forecast by Type (2025-2030)
Table 77. Global Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2024)
Table 78. Global Antibody Drug Conjugates (ADCs) Consumption Value Forecast by Application (2025-2030)
Table 79. North America Antibody Drug Conjugates (ADCs) Consumption Value by Type (2019-2024) & (USD Million)
Table 80. North America Antibody Drug Conjugates (ADCs) Consumption Value by Type (2025-2030) & (USD Million)
Table 81. North America Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2024) & (USD Million)
Table 82. North America Antibody Drug Conjugates (ADCs) Consumption Value by Application (2025-2030) & (USD Million)
Table 83. North America Antibody Drug Conjugates (ADCs) Consumption Value by Country (2019-2024) & (USD Million)
Table 84. North America Antibody Drug Conjugates (ADCs) Consumption Value by Country (2025-2030) & (USD Million)
Table 85. Europe Antibody Drug Conjugates (ADCs) Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Europe Antibody Drug Conjugates (ADCs) Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Europe Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2024) & (USD Million)
Table 88. Europe Antibody Drug Conjugates (ADCs) Consumption Value by Application (2025-2030) & (USD Million)
Table 89. Europe Antibody Drug Conjugates (ADCs) Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Antibody Drug Conjugates (ADCs) Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value by Type (2019-2024) & (USD Million)
Table 92. Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value by Type (2025-2030) & (USD Million)
Table 93. Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2024) & (USD Million)
Table 94. Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value by Application (2025-2030) & (USD Million)
Table 95. Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value by Region (2019-2024) & (USD Million)
Table 96. Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value by Region (2025-2030) & (USD Million)
Table 97. South America Antibody Drug Conjugates (ADCs) Consumption Value by Type (2019-2024) & (USD Million)
Table 98. South America Antibody Drug Conjugates (ADCs) Consumption Value by Type (2025-2030) & (USD Million)
Table 99. South America Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2024) & (USD Million)
Table 100. South America Antibody Drug Conjugates (ADCs) Consumption Value by Application (2025-2030) & (USD Million)
Table 101. South America Antibody Drug Conjugates (ADCs) Consumption Value by Country (2019-2024) & (USD Million)
Table 102. South America Antibody Drug Conjugates (ADCs) Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Middle East & Africa Antibody Drug Conjugates (ADCs) Consumption Value by Type (2019-2024) & (USD Million)
Table 104. Middle East & Africa Antibody Drug Conjugates (ADCs) Consumption Value by Type (2025-2030) & (USD Million)
Table 105. Middle East & Africa Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2024) & (USD Million)
Table 106. Middle East & Africa Antibody Drug Conjugates (ADCs) Consumption Value by Application (2025-2030) & (USD Million)
Table 107. Middle East & Africa Antibody Drug Conjugates (ADCs) Consumption Value by Country (2019-2024) & (USD Million)
Table 108. Middle East & Africa Antibody Drug Conjugates (ADCs) Consumption Value by Country (2025-2030) & (USD Million)
Table 109. Antibody Drug Conjugates (ADCs) Raw Material
Table 110. Key Suppliers of Antibody Drug Conjugates (ADCs) Raw Materials
Table 1. Global Antibody Drug Conjugates (ADCs) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Antibody Drug Conjugates (ADCs) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Antibody Drug Conjugates (ADCs) Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Antibody Drug Conjugates (ADCs) Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Antibody Drug Conjugates (ADCs) Product and Solutions
Table 8. Roche Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Roche Recent Developments and Future Plans
Table 10. Pfizer Company Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Antibody Drug Conjugates (ADCs) Product and Solutions
Table 13. Pfizer Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Pfizer Recent Developments and Future Plans
Table 15. Novartis Company Information, Head Office, and Major Competitors
Table 16. Novartis Major Business
Table 17. Novartis Antibody Drug Conjugates (ADCs) Product and Solutions
Table 18. Novartis Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Novartis Recent Developments and Future Plans
Table 20. Genmab Company Information, Head Office, and Major Competitors
Table 21. Genmab Major Business
Table 22. Genmab Antibody Drug Conjugates (ADCs) Product and Solutions
Table 23. Genmab Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Genmab Recent Developments and Future Plans
Table 25. Bayer Company Information, Head Office, and Major Competitors
Table 26. Bayer Major Business
Table 27. Bayer Antibody Drug Conjugates (ADCs) Product and Solutions
Table 28. Bayer Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Bayer Recent Developments and Future Plans
Table 30. Seattle Genetics Company Information, Head Office, and Major Competitors
Table 31. Seattle Genetics Major Business
Table 32. Seattle Genetics Antibody Drug Conjugates (ADCs) Product and Solutions
Table 33. Seattle Genetics Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Seattle Genetics Recent Developments and Future Plans
Table 35. Takeda Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 36. Takeda Pharmaceuticals Major Business
Table 37. Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Product and Solutions
Table 38. Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Takeda Pharmaceuticals Recent Developments and Future Plans
Table 40. AbbVie Company Information, Head Office, and Major Competitors
Table 41. AbbVie Major Business
Table 42. AbbVie Antibody Drug Conjugates (ADCs) Product and Solutions
Table 43. AbbVie Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. AbbVie Recent Developments and Future Plans
Table 45. AbGenomics Company Information, Head Office, and Major Competitors
Table 46. AbGenomics Major Business
Table 47. AbGenomics Antibody Drug Conjugates (ADCs) Product and Solutions
Table 48. AbGenomics Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. AbGenomics Recent Developments and Future Plans
Table 50. ADC Therapeutics Company Information, Head Office, and Major Competitors
Table 51. ADC Therapeutics Major Business
Table 52. ADC Therapeutics Antibody Drug Conjugates (ADCs) Product and Solutions
Table 53. ADC Therapeutics Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. ADC Therapeutics Recent Developments and Future Plans
Table 55. Astellas Pharma Company Information, Head Office, and Major Competitors
Table 56. Astellas Pharma Major Business
Table 57. Astellas Pharma Antibody Drug Conjugates (ADCs) Product and Solutions
Table 58. Astellas Pharma Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Astellas Pharma Recent Developments and Future Plans
Table 60. Kairos Therapeutics Company Information, Head Office, and Major Competitors
Table 61. Kairos Therapeutics Major Business
Table 62. Kairos Therapeutics Antibody Drug Conjugates (ADCs) Product and Solutions
Table 63. Kairos Therapeutics Antibody Drug Conjugates (ADCs) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Kairos Therapeutics Recent Developments and Future Plans
Table 65. Global Antibody Drug Conjugates (ADCs) Revenue (USD Million) by Players (2019-2024)
Table 66. Global Antibody Drug Conjugates (ADCs) Revenue Share by Players (2019-2024)
Table 67. Breakdown of Antibody Drug Conjugates (ADCs) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Antibody Drug Conjugates (ADCs), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 69. Head Office of Key Antibody Drug Conjugates (ADCs) Players
Table 70. Antibody Drug Conjugates (ADCs) Market: Company Product Type Footprint
Table 71. Antibody Drug Conjugates (ADCs) Market: Company Product Application Footprint
Table 72. Antibody Drug Conjugates (ADCs) New Market Entrants and Barriers to Market Entry
Table 73. Antibody Drug Conjugates (ADCs) Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Antibody Drug Conjugates (ADCs) Consumption Value (USD Million) by Type (2019-2024)
Table 75. Global Antibody Drug Conjugates (ADCs) Consumption Value Share by Type (2019-2024)
Table 76. Global Antibody Drug Conjugates (ADCs) Consumption Value Forecast by Type (2025-2030)
Table 77. Global Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2024)
Table 78. Global Antibody Drug Conjugates (ADCs) Consumption Value Forecast by Application (2025-2030)
Table 79. North America Antibody Drug Conjugates (ADCs) Consumption Value by Type (2019-2024) & (USD Million)
Table 80. North America Antibody Drug Conjugates (ADCs) Consumption Value by Type (2025-2030) & (USD Million)
Table 81. North America Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2024) & (USD Million)
Table 82. North America Antibody Drug Conjugates (ADCs) Consumption Value by Application (2025-2030) & (USD Million)
Table 83. North America Antibody Drug Conjugates (ADCs) Consumption Value by Country (2019-2024) & (USD Million)
Table 84. North America Antibody Drug Conjugates (ADCs) Consumption Value by Country (2025-2030) & (USD Million)
Table 85. Europe Antibody Drug Conjugates (ADCs) Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Europe Antibody Drug Conjugates (ADCs) Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Europe Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2024) & (USD Million)
Table 88. Europe Antibody Drug Conjugates (ADCs) Consumption Value by Application (2025-2030) & (USD Million)
Table 89. Europe Antibody Drug Conjugates (ADCs) Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Antibody Drug Conjugates (ADCs) Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value by Type (2019-2024) & (USD Million)
Table 92. Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value by Type (2025-2030) & (USD Million)
Table 93. Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2024) & (USD Million)
Table 94. Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value by Application (2025-2030) & (USD Million)
Table 95. Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value by Region (2019-2024) & (USD Million)
Table 96. Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value by Region (2025-2030) & (USD Million)
Table 97. South America Antibody Drug Conjugates (ADCs) Consumption Value by Type (2019-2024) & (USD Million)
Table 98. South America Antibody Drug Conjugates (ADCs) Consumption Value by Type (2025-2030) & (USD Million)
Table 99. South America Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2024) & (USD Million)
Table 100. South America Antibody Drug Conjugates (ADCs) Consumption Value by Application (2025-2030) & (USD Million)
Table 101. South America Antibody Drug Conjugates (ADCs) Consumption Value by Country (2019-2024) & (USD Million)
Table 102. South America Antibody Drug Conjugates (ADCs) Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Middle East & Africa Antibody Drug Conjugates (ADCs) Consumption Value by Type (2019-2024) & (USD Million)
Table 104. Middle East & Africa Antibody Drug Conjugates (ADCs) Consumption Value by Type (2025-2030) & (USD Million)
Table 105. Middle East & Africa Antibody Drug Conjugates (ADCs) Consumption Value by Application (2019-2024) & (USD Million)
Table 106. Middle East & Africa Antibody Drug Conjugates (ADCs) Consumption Value by Application (2025-2030) & (USD Million)
Table 107. Middle East & Africa Antibody Drug Conjugates (ADCs) Consumption Value by Country (2019-2024) & (USD Million)
Table 108. Middle East & Africa Antibody Drug Conjugates (ADCs) Consumption Value by Country (2025-2030) & (USD Million)
Table 109. Antibody Drug Conjugates (ADCs) Raw Material
Table 110. Key Suppliers of Antibody Drug Conjugates (ADCs) Raw Materials
LIST OF FIGURES
Figure 1. Antibody Drug Conjugates (ADCs) Picture
Figure 2. Global Antibody Drug Conjugates (ADCs) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Type in 2023
Figure 4. Seattle Genetics Technology
Figure 5. ImmunoGen Technology
Figure 6. Immunomedics Technology
Figure 7. Global Antibody Drug Conjugates (ADCs) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Application in 2023
Figure 9. Hospital Picture
Figure 10. Clinics Picture
Figure 11. Others Picture
Figure 12. Global Antibody Drug Conjugates (ADCs) Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Antibody Drug Conjugates (ADCs) Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Antibody Drug Conjugates (ADCs) Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Region in 2023
Figure 17. North America Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Antibody Drug Conjugates (ADCs) Revenue Share by Players in 2023
Figure 23. Antibody Drug Conjugates (ADCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Antibody Drug Conjugates (ADCs) Market Share in 2023
Figure 25. Global Top 6 Players Antibody Drug Conjugates (ADCs) Market Share in 2023
Figure 26. Global Antibody Drug Conjugates (ADCs) Consumption Value Share by Type (2019-2024)
Figure 27. Global Antibody Drug Conjugates (ADCs) Market Share Forecast by Type (2025-2030)
Figure 28. Global Antibody Drug Conjugates (ADCs) Consumption Value Share by Application (2019-2024)
Figure 29. Global Antibody Drug Conjugates (ADCs) Market Share Forecast by Application (2025-2030)
Figure 30. North America Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 40. France Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Region (2019-2030)
Figure 47. China Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 50. India Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 64. Antibody Drug Conjugates (ADCs) Market Drivers
Figure 65. Antibody Drug Conjugates (ADCs) Market Restraints
Figure 66. Antibody Drug Conjugates (ADCs) Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Antibody Drug Conjugates (ADCs) in 2023
Figure 69. Manufacturing Process Analysis of Antibody Drug Conjugates (ADCs)
Figure 70. Antibody Drug Conjugates (ADCs) Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Antibody Drug Conjugates (ADCs) Picture
Figure 2. Global Antibody Drug Conjugates (ADCs) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Type in 2023
Figure 4. Seattle Genetics Technology
Figure 5. ImmunoGen Technology
Figure 6. Immunomedics Technology
Figure 7. Global Antibody Drug Conjugates (ADCs) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Application in 2023
Figure 9. Hospital Picture
Figure 10. Clinics Picture
Figure 11. Others Picture
Figure 12. Global Antibody Drug Conjugates (ADCs) Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Antibody Drug Conjugates (ADCs) Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Antibody Drug Conjugates (ADCs) Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Region in 2023
Figure 17. North America Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Antibody Drug Conjugates (ADCs) Revenue Share by Players in 2023
Figure 23. Antibody Drug Conjugates (ADCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Antibody Drug Conjugates (ADCs) Market Share in 2023
Figure 25. Global Top 6 Players Antibody Drug Conjugates (ADCs) Market Share in 2023
Figure 26. Global Antibody Drug Conjugates (ADCs) Consumption Value Share by Type (2019-2024)
Figure 27. Global Antibody Drug Conjugates (ADCs) Market Share Forecast by Type (2025-2030)
Figure 28. Global Antibody Drug Conjugates (ADCs) Consumption Value Share by Application (2019-2024)
Figure 29. Global Antibody Drug Conjugates (ADCs) Market Share Forecast by Application (2025-2030)
Figure 30. North America Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 40. France Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Region (2019-2030)
Figure 47. China Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 50. India Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Antibody Drug Conjugates (ADCs) Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Antibody Drug Conjugates (ADCs) Consumption Value (2019-2030) & (USD Million)
Figure 64. Antibody Drug Conjugates (ADCs) Market Drivers
Figure 65. Antibody Drug Conjugates (ADCs) Market Restraints
Figure 66. Antibody Drug Conjugates (ADCs) Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Antibody Drug Conjugates (ADCs) in 2023
Figure 69. Manufacturing Process Analysis of Antibody Drug Conjugates (ADCs)
Figure 70. Antibody Drug Conjugates (ADCs) Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
